C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 5/06 (2006.01) A61K 47/48 (2006.01) C07K 5/103 (2006.01) C07K 5/117 (2006.01) C07K 9/00 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2472296
The invention relates to a prodrug that is capable of being converted into a drug by the catalytic action of human fibroblast activation protein (FAP.alpha.), said prodrug is chemically stable under physiological conditions and can be used for the manufacture of physically stable aqueous formulations. It has a cleavage site which is recognised by FAP.alpha., and the drug released by the enzymatic activity of FAP.alpha. is cytotoxic or cytostatic under physiological conditions.
L'invention concerne un promédicament pouvant être transformé en un médicament par l'action catalytique de la protéine d'activation des fibroblastes humains (FAP.alpha.), ledit promédicament étant chimiquement stable dans des conditions physiologiques et pouvant être utilisé dans la fabrication de formulations aqueuses physiquement stables. Ce promédicament présente un site de clivage qui est reconnu par la protéine FAP.alpha., et le médicament libéré par l'activité enzymatique de la protéine FAP.alpha. est cytotoxique ou cytostatique dans des conditions physiologiques.
Blech Stefan Matthias
Breitfelder Steffen
Garin-Chesa Pilar
Lenter Martin
Park John Edward
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Fetherstonhaugh & Co.
LandOfFree
Fap-activated anti-tumor compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fap-activated anti-tumor compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fap-activated anti-tumor compounds will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1490397